Amphista Therapeutics’ Series B Extension Investment

Bird & Bird has advised the Dementia Discovery Fund on the deal.The investment will enable Amphista to accelerate the application of its technology into indications largely…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Giulia Di Palma

Author: Giulia Di Palma

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here